2024

• Andrew M. Peseski, Sargam Kapoor, Maragatha Kuchibhatla, Alys Adamski, Karon Abe, Michele G. Beckman, Nimia L. Reyes, Lisa C. Richardson, Ibrahim Saber, Ryan Schulteis, Bhavana Pendurthi Singh, Andrea Sitlinger, Elizabeth H. Thames, Thomas L. Ortel. An epidemiologic study comparing cancer- and noncancer-associated venous thromboembolism in a racially diverse Southeastern United States county. Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 4, May 2024, 102420. PMID: 38817950
• Zhou, Katherine I., Chenyu Lin, Chin-Lin Tseng, Nithya Ramnath, Jonathan E. Dowell, and Michael J. Kelley. “Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C-Mutated NSCLC.” JTO Clinical and Research Reports 5, no. 5 (May 2024): 100670. https://doi.org/10.1016/j.jtocrr.2024.100670.
• Zhou, Katherine I., Chad V. Pecot, and Christopher L. Holley. “2′-O-methylation (Nm) in RNA: progress, challenges, and future directions.” RNA 30, no. 5 (April 16, 2024): 570–82. https://doi.org/10.1261/rna.079970.124.
• David H Noyd, Anna Bailey, Amanda Janitz, Talayeh Razzaghi, Sharon Bouvette 4. Rurality, Cardiovascular Risk Factors, and Early Cardiovascular Disease among Childhood, Adolescent, and Young Adult Cancer Survivors. PMID: 38645102. PMCID: PMC11030544. DOI: 10.21203/rs.3.rs-4139837/v1. 2024 Apr 1:rs.3.rs-4139837. doi: 10.21203/rs.3.rs-4139837/v1.
• Akshay Bareja 1, David E Lee 1, Tricia Ho 2, Greg Waitt 2, Lauren H McKay 3, Sarah A Hannou, James P White. Liver-derived plasminogen mediates muscle stem cell expansion during caloric restriction through the plasminogen receptor Plg-RKT. PMID: 38442019 PMCID: PMC11075744 DOI: 10.1016/j.celrep.2024.113881

2023

• Andrew M. Peseski, Ortel, Gloria Broadwater, Claire Bradbury, Margaret O. Johnson. Published in Blood 28 November 2023. Medicine Treatment Complications of Venous Thromboembolism in Patients with Central Nervous System Tumors. DOI:10.1182/blood-2023-188818 Corpus ID: 265600531

• Zhou, Katherine I., Brent A. Hanks, and John H. Strickler. “Management of Microsatellite Instability High (MSI-H) Gastroesophageal Adenocarcinoma.” J Gastrointest Cancer, December 22, 2023. PMID: 38133871    https://pubmed.ncbi.nlm.nih.gov/38133871/
• https://doi.org/10.1007/s12029-023-01003-5

• Zhou, Katherine Ismei, Sargam Kapoor, and Oluwatoyosi Adefunke Onwuemene. “Surprise diagnosis of acquired von Willebrand syndrome in a patient previously thought to have type III von Willebrand disease: evaluation and periprocedural management.” BMJ Case Rep 16, no. 12 (December 6, 2023). https://doi.org/10.1136/bcr-2023-257760.
• Lin, Chenyu, Katherine Zhou, Zachary Burningham, Kerry Rowe, Tori Anglin-Foote, Mark Maddox, Daphne Friedman, et al. “Telemedicine-Supervised Cancer Therapy for Patients with an Aggressive Lymphoma and Metastatic Lung Cancer in the U.S. Veteran Affairs National Teleoncology Service.” In Journal of Clinical Oncology, 41:Suppl-Suppl. American Society of Clinical Oncology, 2023.
• Zhou, Katherine, Chenyu Lin, Chin-Lin Tseng, Nithya Ramnath, Jonathan Dowell, and Michael Kelley, eds. “Real World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C Mutated Non-Small Cell Lung Cancer,” 2023.
• Zhou, Katherine I., and Michael J. Kelley. “Reply to M.S. Brose et al.” JCO Precis Oncol 7 (September 2023): e2300275. https://doi.org/10.1200/PO.23.00275.
• Lin, Chenyu, Aurelie Schwarzbach, Jaime Sanz, Pau Montesinos, Patrick Stiff, Suhag Parikh, Claudio Brunstein, et al. “Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.” In Transplant Cell Ther, 29:338.e1-338.e6, 2023. https://doi.org/10.1016/j.jtct.2023.01.031.

2022

• Chenyu Lin , Rachel A DiCioccio , Tarek Haykal , William C McManigle..Stefanie Sarantopoulos. A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease: SYK Inhibition in Chronic GVHD. Lin et al. Transplant Cell Ther, Dec 2022. PMID: 36577483. PMCID: PMC10433369 . DOI: 1016/j.jtct.2022.12.015 . https://pubmed.ncbi.nlm.nih.gov/36577483/
• Chenyu Lin , MD,Ahmed Galal , MD,David Rizzieri , MD,Sant Chawla , MD,Seung Lee , MD,Angela Georgy , PharmD,Kristina Dabovic , PharmD,Thomas Strack , MD &Matthew McKinney , MD. Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma. Lin et al. Cancer Investigation, Jan 2023.Chenyu Lin, Mitchell E. Horwitz, and Lindsay A. M. Rein. Leveraging Natural Killer Cell Innate Immunity against Hematologic Malignancies: From Stem Cell Transplant to Adoptive Transfer and Beyond. Lin et al., Int J Mol Sci, Dec 2022. PMCID: PMC9820370. PMID: 36613644.
• Chenyu Lin, Gautam Sajeev, Patrick J Stiff, Claudio G. Brunstein, Corey Cutler, Guillermo Sanz, Caroline A. Lindermans, Andrew R. Resvani, Rabi Hanna, Liang Piu Koh, Richard T. Maziarz, William Y.K. Hwang, Yan Song, Qing Liu, Rocio Manghani, Smitha Sivaram, James Signorovitch, Mitchell E. Horwitz, Anthony D Sung. Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel Versus Umbilical Cord Blood. Transplantation and Cellular Therapy, 28 September 2022. PMID: 36179986. PMCID: PMC9825638
• Charity I. Oyedeji, John J Strouse, Rita Masese, Nathan Gray, Tolu O Oyesanya. ”Death is as Much Part of Life as Living”: Attitudes and Experiences Preparing for Death from Older Adults with Sickle Cell Disease. PMID: 35857485 https://pubmed.ncbi.nlm.nih.gov/35857485/
• Charity I. Oyedeji, Katherine Hall, Alison Luciano, Miriam C. Morey & John J. Strouse. The Sickle Cell Disease Functional Assessment (SCD-FA) tool: a feasibility pilot study. Pilot and Feasibility Studies volume 8, Article number: 53 (2022) https://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-022-01005-3

2021

1. Oyedeji CI. Optimizing management of sickle cell disease in patients undergoing surgery.  2021 Dec 10. PMID: 34889383.
2. Chenyu Lin. Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma. 2021 Nov. PMID: 34643126.
3. David Noyd. Integration of cancer registry and electronic health record data to construct a childhood cancer survivorship cohort, facilitate risk stratification for late effects, and assess appropriate follow-up care. 2021 Jun. PMID: 33742534.
4. Charity Oyedeji. Adherence to Iron Chelation Therapy with Deferasirox Formulations among Patients with Sickle Cell Disease and β-thalassemia.  2021 Apr. PMID: 32892996.
5. David Noyd. Advances in the Diagnosis and Management of Neonatal Sarcomas. 2021 Mar. PMID: 33583500.
6. David Noyd. Sweet Syndrome in Pediatric Acute Myeloid Leukemia.  2021 Jan. PMID: 32925399. PMCID: PMC7736186.

2020

1. Molly Daughety. COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy. 2020 Dec. PubMed PMID: 33091700. PMCID: PMC7557260.
2. Charity Oyedeji. Geriatric assessment for older adults with sickle cell disease: protocol for a prospective cohort pilot study.  2020. PMID: 32974042; PMCID: PMC7495855.
3. David Lee. Author Correction: Meteorin-like facilitates skeletal muscle repair through a Stat3/IGF-1 mechanism.  2020 Aug; PMID: 32694832.
4. Chenyu Lin. Long-term antithrombotic therapy after venous stent placement.  2020 Jul; PubMed PMID: 31821779.
5. Charity Oyedeji. Improving the Quality of Care for Adolescents and Adults With Sickle Cell Disease-It’s a Long Road. 2020 May. PMID: 32469408.
6. David Lee. Meteorin-like facilitates skeletal muscle repair through a Stat3/IGF-1 mechanism.  2020 Mar. PMID: 32694780; PMCID: PMC7504545.
7. Molly Daughety. Management of Anticoagulation in Pregnant Women With Mechanical Heart Valves.  2020 Mar. PubMed PMID: 32232497.

2019